Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Coinbase Lists First GBP Stablecoin, Expanding Market Options

The new stablecoin aims to enhance trading in the UK market.Highlights: Coinbase has launched the first GBP stablecoin.This...

Former Royal Mint Executives Secure Backing for Precious Metals Trading Platform

New platform aims to modernize precious metals trading for investors.Highlights: Former Royal Mint executives launch a new trading...

Coastal Bank Partners with Tempo to Strengthen Cross-Border Money Transfers

The partnership aims to enhance international money movement solutions.Highlights: Coastal Bank has partnered with Tempo for improved cross-border...

Lloyds Accelerates Homebuying with Fully Digital Service

New platform aims to reduce waiting times for mortgage approvals.Highlights: Lloyds introduces a fully digital homebuying service.Service aims...